Literature DB >> 10877732

Extent of hyperbaric spinal anesthesia influences the duration of spinal block.

N E Kooger Infante1, E Van Gessel, A Forster, Z Gamulin.   

Abstract

BACKGROUND: The influence of spread of spinal anesthesia on the duration of spinal blockade has been suggested but never investigated specifically. Because elimination of local anesthetic from subarachnoid space is probably dependent of the surface available for its diffusion and vascular absorption, the current study was designed to evaluate the hypothesis that with a same dose of hyperbaric bupivacaine, a higher anesthetic level would result in a shorter duration of spinal blockade than a lower level.
METHODS: Three milliliters (15 mg) of hyperbaric bupivacaine, 0.5%, was injected intrathecally in 40 patients classified as American Society of Anesthesiologists physical status I or H scheduled for lower limb surgery during spinal anesthesia. To obtain significantly different anesthetic levels, the patients were positioned randomly either horizontally or with the torso elevated 30. Regression of sensory level and motor blockade, the appearance of pain at the operative site, and hemodynamic changes were evaluated.
RESULTS: The maximum cephalad spread of sensory blockade (expressed as the median with ranges in parentheses) was significantly higher in the horizontal group than in the group with 30-degree elevation of the torso, i.e., T3.5 (T1-T9) versus T10 (T6-L1), with respectively significantly faster regression times (mean ¿ SD) by two segments (216 ¿ 46 mm vs. 253 ¿ 64 mm) and to segment L4 (269 ¿ 53 mm i s. 337 ¿ 58 mm), as well as shorter time to complete motor blockade recovery (173 ¿ 34 mm i s. 233 ¿ 58 mm) and faster appearance of pain at the operative site (221 ¿ 68 mm vs. 271 ¿ 56 mm).
CONCLUSION: The results indicate that with the same dose of hyperbaric bupivacaine, the duration of spinal blockade is longer in patients with restricted spread.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10877732     DOI: 10.1097/00000542-200005000-00020

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  7 in total

1.  [Spinal anaesthesia in day-case surgery. Optimisation of procedures].

Authors:  G Rätsch; H Niebergall; L Hauenstein; A Reber
Journal:  Anaesthesist       Date:  2007-04       Impact factor: 1.041

2.  Practicability and patients' subjective experiences of low-dose spinal anaesthesia using hyperbaric bupivacaine for transanal surgery.

Authors:  Marc D Schmittner; Andrea Janke; Christel Weiss; Grietje C Beck; Dieter G Bussen
Journal:  Int J Colorectal Dis       Date:  2009-03-13       Impact factor: 2.571

3.  Spinal anaesthesia with hyperbaric prilocaine in day-case perianal surgery: randomised controlled trial.

Authors:  Ozden Gorgoz Kaban; Dilek Yazicioglu; Taylan Akkaya; M Murat Sayin; Duray Seker; Haluk Gumus
Journal:  ScientificWorldJournal       Date:  2014-10-14

Review 4.  Prilocaine hydrochloride 2% hyperbaric solution for intrathecal injection: a clinical review.

Authors:  Alberto Manassero; Andrea Fanelli
Journal:  Local Reg Anesth       Date:  2017-03-31

5.  Dural sac cross-sectional area is a highly effective parameter for spinal anesthesia in geriatric patients undergoing transurethral resection of the prostate: a prospective, double blinded, randomized study.

Authors:  Wei Bing Wang; Ai Jiao Sun; Hong Ping Yu; Jing Chun Dong; Huang Xu
Journal:  BMC Anesthesiol       Date:  2020-06-03       Impact factor: 2.217

6.  Investigating the Effect of the 10° Reverse Trendelenburg Position on Spinal Block Characteristics and Hemodynamic Parameters in Lower Limb Surgeries.

Authors:  Mahesh Kumar; Shyam Bhandari; Aman Thakur; Sunil Thakur; Ravinder Verma; Bhanu Awasthi
Journal:  Cureus       Date:  2022-02-25

7.  Effectiveness of Ultrasound-guided Single-injection Triple Nerve Block Before Cementless Bipolar Hip Hemiarthroplasty in Femoral Neck Fractures.

Authors:  Jung-Wook Huh; Man-Jun Park; Woo-Myung Lee; Dong-Ha Lee
Journal:  Hip Pelvis       Date:  2020-09-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.